RNS Number : 1159R
Quadrise PLC
24 October 2023

24 October 2023

Quadrise Plc
("Quadrise" or the "Company")

Change of Nominated Adviser

Quadrise Plc (AIM: QED), the supplier of innovative energy solutions for a cleaner planet, announces that, following the completion of the all share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser from Cavendish Securities plc to Cavendish Capital Markets Limited.

For additional information, please contact:

Quadrise Plc


+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer






Nominated Adviser



Cavendish Capital Markets Limited


+44 (0)20 7220 0500

Ben Jeynes



Katy Birkin



Joint Brokers

Shore Capital Stockbrokers Limited


+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)



Fiona Conroy (Corporate Broking)



VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)


+44 (0)20 3005 5000




Public & Investor Relations

Vigo Consulting

Patrick D'Ancona

Finlay Thomson


+44 (0)20 7390 0230

About Quadrise

Quadrise is the supplier of MSARĀ® and bioMSAR? emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more at: www.quadrise.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPEAPELAANDFEA